Liquid Genomics Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Employees
-
5
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$7.24M
Liquid Genomics General Information
Description
Provider of blood-based biomarker intended to be used for tumor profiling. The company's blood-based biomarker utilizes non-invasive blood-based molecular testing methods enabling cancer patients to assess gene mutations, expressions, and fusions to inform treatment strategies for chemotherapy.
Contact Information
Website
www.liquidgenomics.comCorporate Office
- 9920 Jefferson Boulevard
- Culver City, CA 90501
- United States
Corporate Office
- 9920 Jefferson Boulevard
- Culver City, CA 90501
- United States
Liquid Genomics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 31-Mar-2017 | $7.24M | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A) | 18-Jan-2017 | Completed | Generating Revenue |
Liquid Genomics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Liquid Genomics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Liquid Genomics Patents
Liquid Genomics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20200377955-A1 | Use of cell-free circulating rna (cfrna) expression of pd-l1 and ercc1 in plasma to monitor response to therapy in nsclc | Inactive | 20-Jun-2017 | ||
| US-11168323-B2 | Dna stabilization of rna | Active | 01-Jun-2017 | ||
| US-20200172900-A1 | Dna stabilization of rna | Active | 01-Jun-2017 | ||
| US-20240229022-A1 | Dna stabilization of rna | Inactive | 01-Jun-2017 | ||
| ES-2790823-T3 | Use of circulating cell-free rna for cancer diagnosis and / or monitoring | Active | 14-Nov-2014 | C12Q1/6806 |
Liquid Genomics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Liquid Genomics FAQs
-
When was Liquid Genomics founded?
Liquid Genomics was founded in 2013.
-
Where is Liquid Genomics headquartered?
Liquid Genomics is headquartered in Culver City, CA.
-
What is the size of Liquid Genomics?
Liquid Genomics has 5 total employees.
-
What industry is Liquid Genomics in?
Liquid Genomics’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Liquid Genomics a private or public company?
Liquid Genomics is a Private company.
-
What is the current valuation of Liquid Genomics?
The current valuation of Liquid Genomics is .
-
What is Liquid Genomics’s current revenue?
The current revenue for Liquid Genomics is .
-
How much funding has Liquid Genomics raised over time?
Liquid Genomics has raised $4.86M.
-
When was Liquid Genomics acquired?
Liquid Genomics was acquired on 31-Mar-2017.
-
Who acquired Liquid Genomics?
Liquid Genomics was acquired by ImmunityBio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
